Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LEXX stock hub

Lexaria Bioscience Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LEXXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LEXX

In the news

Latest news · LEXX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-147.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-87.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LEXX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001348362
Company name	Lexaria Bioscience Corp.
Country	Canada
Country code	US
Cusip	52886N406
Employees	7
Employees Change	2%
Employees Change Percent	40
Enterprise value	$9.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US52886N4060
Last refreshed	2026-05-10
Market cap	$15.1M
Market cap category	Nano-Cap
Price	$0.61
Price currency	USD
Rev Per Employee	52,571.43x
Sector	Healthcare
Sic	2834
Symbol	LEXX
Website	https://lexariabioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-63.05%
EV/Sales	27.01x
FCF yield	-62.29%
P/B ratio	2.3x
P/S ratio	41.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$368,000
Gross Profit Growth	-29.66%
Gross Profit Growth Q	-88.51%
Gross Profit Growth3 Y	13.76%
Gross Profit Growth5 Y	-8.52%
Net Income	$-9.5M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-2,590.67%
Profit Per Employee	$-1.4M
ROA	-75.97
Roa5y	-65.6
ROCE	-146.9
ROE	-147.1
Roe5y	-123.8
ROIC	-87.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-15.52%
Cagr15y	-18.26%
Cagr1y	-41.39%
Cagr3y	-22.49%
Cagr5y	-37.24%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-30.03x
Revenue Growth Q	-88.51x
Revenue Growth Years	2x
Revenue Growth3 Y	3.84x
Revenue Growth5 Y	-12.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$6.5M
Cash	$5.3M
Current Assets	$5.8M
Current Liabilities	$214,671
Debt	$94,386
Debt Equity	$0.02
Equity	$6.2M
Liabilities	$276,997
Long Term Assets	$717,021
Long Term Liabilities	$62,326
Net Cash	$5.2M
Net Cash By Market Cap	$34.24
Net Cash Growth	-19.38%
Net Debt Equity	$-0.83
Tangible Book Value	$6.3M
Tangible Book Value Per Share	$0.25
WACC	6.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.88
Net Working Capital	$318,264
Quick ratio	24.74
Working Capital	$5.6M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.3%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-81.49%
1Y total return	-41.37%
200-day SMA	0.88
3Y total return	-53.45%
50-day SMA	0.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.26%
All Time High	180
All Time High Change	-99.66%
All Time High Date	2007-10-10
All Time Low	0.22
All Time Low Change	179.47%
All Time Low Date	2012-11-21
ATR	0.09
Beta	0.36
Beta1y	0.42
Beta2y	0.63
Ch YTD	-1.17
High	0.65
High52	1.55
High52 Date	2025-09-25
High52ch	-60.66%
Low	0.6
Low52	0.46
Low52 Date	2025-12-26
Low52ch	32.57%
Ma50ch	-25.01%
Premarket Change Percent	5.21
Premarket Price	$0.67
Premarket Volume	101
Price vs 200-day SMA	-30.79%
RSI	32.01
RSI Monthly	37.76
RSI Weekly	41.8
Sharpe ratio	-0.02x
Sortino ratio	0.02
Total Return	-31.3%
Tr YTD	-1.17
Tr15y	-95.14%
Tr1m	-38.4%
Tr1w	-14.27%
Tr3m	-15.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	70,000x
Earnings Revenue Estimate Growth	-59.77x
Operating Income	$-9.2M
Operating margin	-2,504.7
Price target	$1.5
Price Target Change	$146

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,438,682%
Float Percent	94.56%
Shares Insiders	4.09%
Shares Institutions	6.62%
Shares Out	24,787,446
Shares Qo Q	14.35%
Shares Yo Y	31.3%
Short Float	1.63%
Short Ratio	1.98
Short Shares	1.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.2M
Average Volume	204,096.2x
Bv Per Share	0.27
CAPEX	$-40,816
Ch10y	-81.49
Ch15y	-95.14
Ch1m	-38.4
Ch1w	-14.27
Ch1y	-41.37
Ch3m	-15.89
Ch3y	-53.45
Ch5y	-90.26
Ch6m	-41.37
Change	-4.82%
Change From Open	-4.06
Close	0.64
Days Gap	-0.8
Depreciation Amortization	88,320
Dollar Volume	164,364.9
Earnings Date	2026-04-13
EBIT	$-9.2M
EBITDA	$-9.1M
EPS	$-0.46
F Score	3
FCF	$-9.4M
FCF EV Yield	-94.72x
FCF Per Share	$-0.38
Financing CF	8,207,155
Fiscal Year End	August
Founded	2,004
Income Tax	$4,389
Investing CF	-236,329
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-13
Last Report Date	2026-02-28
Last Split Date	2021-01-12
Last Split Type	Reverse
Last10k Filing Date	2025-11-28
Ma150	0.84
Ma150ch	-27.83%
Ma20	0.85
Ma20ch	-28.37%
Net CF	-1,340,793
Next Earnings Date	2026-07-13
Open	0.64
Optionable	No
Position In Range	17.62
Post Close	0.61
Postmarket Change Percent	6.59
Postmarket Price	$0.65
Ppne	334,949
Pre Close	0.64
Price Date	2026-05-08
Ptbv Ratio	2.41
Relative Volume	1.32x
Revenue	368,000x
SBC By Revenue	201.81x
Share Based Comp	742,650
Tax By Revenue	1.19x
Tr6m	-41.37%
Volume	269,539
Z Score	26.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LEXX pay a dividend?

Capital-return profile for this ticker.

Performance

LEXX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LEXX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.6%

Float: +94.6% of shares outstanding

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LEXX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.0

Neutral momentum band

Price vs 200-day MA

-30.8%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

-0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LEXX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LEXX stock rating?

Lexaria Bioscience Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LEXX analysis?

The full report lives at /stocks/LEXX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LEXX?

The latest report frames LEXX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LEXX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.